Cengild Medical Berhad (KLSE:CENGILD)
0.210
0.00 (0.00%)
At close: Mar 9, 2026
Cengild Medical Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2018 |
| Market Capitalization | 175 | 192 | 262 | 329 | 328 | - | Upgrade
|
| Market Cap Growth | -25.00% | -26.98% | -20.25% | 0.45% | - | - | Upgrade
|
| Enterprise Value | 192 | 138 | 188 | 255 | 331 | - | Upgrade
|
| Last Close Price | 0.21 | 0.22 | 0.30 | 0.36 | 0.36 | - | Upgrade
|
| PE Ratio | 15.72 | 17.33 | 23.68 | 24.76 | 34.88 | - | Upgrade
|
| Forward PE | - | 23.00 | 23.00 | 23.00 | 24.24 | - | Upgrade
|
| PS Ratio | 2.33 | 2.40 | 3.93 | 4.68 | 5.08 | - | Upgrade
|
| PB Ratio | 1.50 | 1.67 | 2.36 | 3.10 | 3.52 | - | Upgrade
|
| P/TBV Ratio | 1.50 | 1.67 | 2.36 | 3.10 | 3.52 | - | Upgrade
|
| P/FCF Ratio | - | - | - | 27.92 | 21.98 | - | Upgrade
|
| P/OCF Ratio | 25.23 | 11.91 | 20.28 | 23.65 | 21.37 | - | Upgrade
|
| PEG Ratio | - | 0.64 | 0.64 | 0.64 | 0.67 | - | Upgrade
|
| EV/Sales Ratio | 2.57 | 1.72 | 2.82 | 3.62 | 5.14 | - | Upgrade
|
| EV/EBITDA Ratio | 10.98 | 7.10 | 11.94 | 15.59 | 22.72 | - | Upgrade
|
| EV/EBIT Ratio | 16.97 | 9.60 | 14.24 | 17.60 | 28.61 | - | Upgrade
|
| EV/FCF Ratio | -3.36 | - | - | 21.60 | 22.21 | - | Upgrade
|
| Debt / Equity Ratio | 0.71 | 0.42 | 0.07 | 0.14 | 0.17 | 1.76 | Upgrade
|
| Debt / EBITDA Ratio | 4.97 | 2.28 | 0.47 | 0.85 | 1.01 | 1.25 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 1.27 | 1.09 | 1.92 | Upgrade
|
| Net Debt / Equity Ratio | 0.15 | -0.33 | -0.74 | -0.79 | -0.76 | 1.25 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.12 | -1.94 | -5.22 | -5.15 | -4.87 | 0.98 | Upgrade
|
| Net Debt / FCF Ratio | -0.30 | 1.78 | 29.40 | -7.14 | -4.76 | 1.36 | Upgrade
|
| Asset Turnover | 0.38 | 0.51 | 0.51 | 0.56 | 0.78 | 1.36 | Upgrade
|
| Inventory Turnover | 18.34 | 22.93 | 23.09 | 31.23 | 36.62 | 42.83 | Upgrade
|
| Quick Ratio | 3.80 | 4.78 | 6.59 | 9.17 | 7.91 | 1.06 | Upgrade
|
| Current Ratio | 3.90 | 4.91 | 6.73 | 9.32 | 8.04 | 1.16 | Upgrade
|
| Return on Equity (ROE) | 9.58% | 12.02% | 11.01% | 13.35% | 17.60% | 84.90% | Upgrade
|
| Return on Assets (ROA) | 3.33% | 5.72% | 6.25% | 7.19% | 8.74% | 19.43% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.00% | 20.41% | 37.02% | 50.17% | 33.82% | 33.92% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.30% | 8.90% | 11.20% | 12.00% | 10.70% | 41.30% | Upgrade
|
| Earnings Yield | 5.54% | 5.77% | 4.22% | 4.04% | 2.87% | - | Upgrade
|
| FCF Yield | -32.73% | -11.06% | -1.07% | 3.58% | 4.55% | - | Upgrade
|
| Dividend Yield | 4.62% | 4.35% | 2.51% | 2.04% | 1.03% | - | Upgrade
|
| Payout Ratio | 83.40% | 73.07% | 55.64% | 45.60% | - | 72.81% | Upgrade
|
| Buyback Yield / Dilution | 0.02% | 0.11% | -1.00% | -27.94% | -7.56% | -4700.00% | Upgrade
|
| Total Shareholder Return | 4.64% | 4.46% | 1.51% | -25.90% | -6.53% | -4700.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.